Tariff decisions have ‘nothing to do’ with the stock market, President Donald Trump said Thursday.
Related Posts
Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.
Where new jobs were in 2024, and potential growth areas in a second Trump term
Health care and government were the top two drivers of job creation in 2023 and 2024, but that could change under a new administration.
European markets set to plummet amid Trump tariff threat
European markets are expected to open sharply lower Monday after U.S. President Donald Trump imposed trade tariffs on several countries and threatened more.